Teladoc Stock Performance
| TDOC Stock | USD 8.87 0.25 2.90% |
The entity has a beta of 1.12, which indicates a somewhat significant risk relative to the market. Teladoc returns are very sensitive to returns on the market. As the market goes up or down, Teladoc is expected to follow. At this point, Teladoc has a negative expected return of -0.0141%. Please make sure to validate Teladoc's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Teladoc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Teladoc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Teladoc is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return 2.9 | Five Day Return (3.06) | Year To Date Return (6.83) | Ten Year Return (53.32) | All Time Return (53.32) |
1 | Acquisition by Evans Jason Eric of 1016 shares of Teladoc subject to Rule 16b-3 | 12/20/2024 |
2 | Teladoc Q4 Earnings Snapshot | 02/26/2025 |
3 | Why Teladoc Stock Is Plummeting Today | 02/27/2025 |
4 | Acquisition by Divita Charles Iii of 507332 shares of Teladoc subject to Rule 16b-3 | 02/28/2025 |
5 | Teladoc Stock Moves -1.36 percent What You Should Know | 03/03/2025 |
6 | Disposition of 3558 shares by Rodrigues Fernando M. of Teladoc at 9.2 subject to Rule 16b-3 | 03/05/2025 |
7 | Acquisition by Adam Vandervoort of 4418 shares of Teladoc subject to Rule 16b-3 | 03/06/2025 |
8 | Teladoc Health Partners With Eli Lilly To Enhance Pharmacy Access For Weight Care Program | 03/07/2025 |
9 | INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC | 03/11/2025 |
10 | Cylinder joins Teladoc Healths Connected Care Program to expand access to virtual digestive care | 03/12/2025 |
11 | Virtual Health Service Market Projected To Witness Substantial Growth 2025-2032Teladoc Health, Amwell, Doctor on Demand | 03/13/2025 |
| Begin Period Cash Flow | 1.1 B |
Teladoc |
Teladoc Relative Risk vs. Return Landscape
If you would invest 946.00 in Teladoc on December 18, 2024 and sell it today you would lose (59.00) from holding Teladoc or give up 6.24% of portfolio value over 90 days. Teladoc is currently does not generate positive expected returns and assumes 4.3666% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Teladoc, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Teladoc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Teladoc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Teladoc, and traders can use it to determine the average amount a Teladoc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TDOC |
Estimated Market Risk
| 4.37 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Teladoc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teladoc by adding Teladoc to a well-diversified portfolio.
Teladoc Fundamentals Growth
Teladoc Stock prices reflect investors' perceptions of the future prospects and financial health of Teladoc, and Teladoc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Teladoc Stock performance.
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.033 | ||||
| Profit Margin | (0.39) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 1.78 B | ||||
| Shares Outstanding | 173.67 M | ||||
| Price To Earning | (21.84) X | ||||
| Price To Book | 1.00 X | ||||
| Price To Sales | 0.58 X | ||||
| Revenue | 2.57 B | ||||
| Gross Profit | 1.82 B | ||||
| EBITDA | (587.01 M) | ||||
| Net Income | (1 B) | ||||
| Cash And Equivalents | 883.7 M | ||||
| Cash Per Share | 5.47 X | ||||
| Total Debt | 1.58 B | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 3.38 X | ||||
| Book Value Per Share | 8.60 X | ||||
| Cash Flow From Operations | 293.68 M | ||||
| Earnings Per Share | (5.87) X | ||||
| Market Capitalization | 1.5 B | ||||
| Total Asset | 3.52 B | ||||
| Retained Earnings | (16.23 B) | ||||
| Working Capital | 722.37 M | ||||
| Current Asset | 151.58 M | ||||
| Current Liabilities | 17.99 M | ||||
About Teladoc Performance
By analyzing Teladoc's fundamental ratios, stakeholders can gain valuable insights into Teladoc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Teladoc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Teladoc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 18.53 | 12.33 | |
| Return On Tangible Assets | (0.56) | (0.58) | |
| Return On Capital Employed | (0.40) | (0.38) | |
| Return On Assets | (0.28) | (0.30) | |
| Return On Equity | (0.67) | (0.71) |
Things to note about Teladoc performance evaluation
Checking the ongoing alerts about Teladoc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Teladoc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Teladoc generated a negative expected return over the last 90 days | |
| Teladoc has high historical volatility and very poor performance | |
| Teladoc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.57 B. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 1.82 B. | |
| Over 76.0% of the company shares are owned by institutional investors | |
| Latest headline from kalkinemedia.com: Virtual Health Service Market Projected To Witness Substantial Growth 2025-2032Teladoc Health, Amwell, Doctor on Demand |
- Analyzing Teladoc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Teladoc's stock is overvalued or undervalued compared to its peers.
- Examining Teladoc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Teladoc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Teladoc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Teladoc's stock. These opinions can provide insight into Teladoc's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |